Patent Assignment
Reel/Frame 061091/0390
Assignment of Assignor's Interest
Recorded: 2022-09-14
Pages: 4
Assignors
YAO, YIHONG
Executed: 2022-04-08
LI, YANFENG
Executed: 2022-04-08
WEI, YUTIAN
Executed: 2022-04-08
ZHU, SHIGUI
Executed: 2022-04-08
YAO, XIN
Executed: 2022-04-08
HUANG, JIAQI
Executed: 2022-04-08
Assignee
CELLULAR BIOPHARMACEUTICAL GROUP HK LTD.
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
Covered Property
(1)
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Application Thereof
Application:
17/911,502 →
Publication:
US 2023/0104705
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062100/0469 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 061091 Frame 0390. Assignor(S) Hereby Confirms the Assignment.
Apr 7, 2023
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: CELLULAR BIOMEDICINE GROUP HK LTD.
Reel/Frame 063268/0124 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →